Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s First Competitive Generic Therapy Approval Comes With A Twist

Aug 10 2018

• By Sue Sutter

Related Content

How FDA Will Take Away A ‘Breakthrough’ Designation

Aug 11 2014

Breakthrough-Style Program For ANDAs Added To House User Fee Bill

May 19 2017

Competitive Generic Therapy Designations Growing Despite Lack Of Guidance

Jun 27 2018

Generic Industry Gets 267 Reasons From FDA To Pursue ANDA Development

Jun 28 2017

Related Companies

Apotex Inc.

Amneal Pharmaceuticals, Inc.

Athenex, Inc.

Baxter International Inc.

Additional Topics

United States Approvals Generic Drugs Pricing Debate Review Pathway Regulation BioPharmaceutical

More from Products

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window